This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Omic Smap Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Eunju Cha
Introduction
Eunju Cha is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work focuses on developing compounds that exhibit high inhibitory abilities on specific enzymes related to cancer progression.
Latest Patents
Eunju Cha holds a patent for a Quinazoline-2,4-diamine derivative and a pharmaceutical composition for preventing or treating cancer. This invention includes a compound, a stereoisomer, a hydrate, or a pharmaceutically acceptable salt that demonstrates a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2). The compound's effectiveness positions it as a valuable option for cancer treatment.
Career Highlights
Eunju Cha is associated with Omic Smap Inc., where he continues to advance his research and development efforts. His innovative approach and dedication to improving cancer therapies have garnered attention in the scientific community.
Collaborations
Eunju Cha collaborates with talented individuals such as Jung Jin Hwang and Sang Eun Park. Their combined expertise enhances the research and development initiatives at Omic Smap Inc.
Conclusion
Eunju Cha's contributions to cancer treatment through his innovative patent highlight the importance of research in pharmaceuticals. His work exemplifies the potential of targeted therapies in combating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile